Assoc. Prof. Dr. Ozra Tabatabaei-Malazy | Medicine | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Ozra Tabatabaei-Malazy | Medicine | Best Researcher Award

Assoc. Prof. Dr. Ozra Tabatabaei-Malazy, Tehran University of Medical Sciences, Iran.

Dr. Ozra Tabatabaei Malazy is a distinguished researcher and academic in endocrinology and metabolism, associated with the Tehran University of Medical Sciences (TUMS) Endocrinology & Metabolism Research Institute (EMRI). Born in Iran in 1966, Dr. Tabatabaei has dedicated her career to improving clinical and public health outcomes, particularly in diabetes and metabolic disorders. With an impressive h-index of 23 (Scopus) and 33 (Google Scholar), she has contributed significantly to scientific knowledge through her expertise in clinical trials, cross-sectional studies, and meta-analyses. Her academic achievements include an MD, MPH, and PhD in Pharmacology, culminating in her current position as Assistant Professor. Dr. Tabatabaei’s influence extends to editorial roles in prominent journals, reflecting her commitment to advancing research quality and ethics. Her work is characterized by a focus on translating research into effective treatments and preventive measures, particularly for non-communicable diseases prevalent in Iran and worldwide.

Professional Profile

scopus

orcid

google scholar

summary of suitability for Best Researcher Award

Dr. Ozra Tabatabaei Malazy demonstrates an impressive track record in medical research, particularly in endocrinology and metabolism. Her extensive educational background, including an MD, an MPH focused on Knowledge Transfer Exchange, and a PhD in Pharmacology, aligns well with the research and clinical demands of the field. With over two decades of dedicated research experience at Tehran University of Medical Sciences, she has contributed to numerous studies on topics like diabetes, metabolic disorders, oxidative stress, and systematic reviews of therapeutic interventions. Her ongoing involvement in research projects, particularly in clinical trials, cross-sectional studies, and meta-analyses, highlights her commitment to advancing scientific knowledge and clinical practices.

🎓 Education 

Dr. Tabatabaei Malazy’s educational background underscores her dedication to both medical practice and research. She earned her General Medical Doctor (MD) degree in 1993, providing a strong foundation in clinical medicine. In 2006, she pursued a Master of Public Health (MPH) at Tehran University of Medical Sciences (TUMS), where her dissertation focused on Knowledge Transfer Exchange (KTE), a critical area for implementing research findings into healthcare practice. Driven by her passion for pharmacology and therapeutic interventions, she further advanced her academic qualifications with a PhD in Pharmacology in 2016. These degrees equipped her with the skills to integrate clinical insights with a population health perspective, fostering her development as a versatile researcher. Today, as an Assistant Professor, Dr. Tabatabaei combines her expertise in medicine, public health, and pharmacology to contribute to the fields of endocrinology and metabolism through her research and clinical trials.

💼    Experience 

Dr. Tabatabaei has a robust career in endocrinology and metabolism, with over two decades at the Tehran University of Medical Sciences’ Endocrinology & Metabolism Research Institute (EMRI). Since 1998, she has served as a research fellow, contributing to groundbreaking research in diabetes and lipid disorders. Additionally, she has been an active reviewer for journals like Iranian Journal of Diabetes & Lipid Disorders and Plos One, among others. Her influence extends to editorial roles, including Section Editor for the Journal of Diabetes and Metabolic Disorders and Plos One. Dr. Tabatabaei’s contributions are enriched by her membership on EMRI’s peer-review committee and her involvement as a guest editor. These positions showcase her commitment to advancing scientific standards. Through her editorial and peer-review work, Dr. Tabatabaei is shaping the quality of research published in her field, ensuring its relevance and integrity in endocrinology and metabolic sciences.

🏅Awards and Honors 

Dr. Tabatabaei’s outstanding contributions to endocrinology and metabolism have earned her numerous awards and honors, recognizing her influence in clinical research. Her editorial appointments across renowned journals such as Plos One and the Journal of Diabetes and Metabolic Disorders underline her authority in the field. Additionally, Dr. Tabatabaei’s role as a guest editor for Frontiers in Endocrinology highlights her expertise and leadership in metabolic research. Her efforts in reviewing and overseeing high-impact research have further contributed to her esteemed status within the academic community. With her impressive h-index metrics—23 in Scopus and 33 in Google Scholar—she is well-regarded for her scholarly impact. Dr. Tabatabaei’s recognitions underscore her commitment to advancing research and influencing global health perspectives, particularly within endocrinology and non-communicable disease prevention.

🌍   Research Focus 

Dr. Tabatabaei’s research primarily centers on non-communicable diseases, particularly diabetes and metabolic disorders. Her studies explore the underlying mechanisms of these conditions, emphasizing risk factors, preventive measures, and therapeutic interventions. Dr. Tabatabaei has contributed to numerous clinical trials and cross-sectional studies, providing valuable insights into the epidemiology and management of metabolic diseases. Her work often includes systematic reviews and meta-analyses, establishing her as a pivotal figure in evidence-based medicine. Dr. Tabatabaei is also actively involved in scientometric studies that analyze research trends and their impact on healthcare practices. Her commitment to research extends to the field of pharmacology, where she examines the effects of natural and synthetic compounds on metabolic health. Through her extensive research, Dr. Tabatabaei aims to develop practical solutions for managing and mitigating the global burden of diabetes and related metabolic disorders.

📖 Publication Top Notes

  • Title: Nurses’ role in diabetic foot prevention and care; a review
    Citation: 259
  • Title: New horizons in treatment of osteoporosis
    Citation: 211
  • Title: Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the …
    Citation: 185
  • Title: Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in …
    Citation: 161
  • Title: Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease .
    Citation: 149

Ms. Havva Mehralitabar | Biophysics | Women Researcher Award

Posted on by sciencefather

Ms. Havva Mehralitabar | Biophysics | Women Researcher Award

Ms. Havva Mehralitabar, Tarbiat modares university, Iran

Dr. Havva Mehralitabar Firozjah, born on December 2, 1985, is a distinguished biophysicist specializing in molecular dynamics simulations, peptide design, and nanotechnology. Currently a researcher at Sari Agricultural Sciences and Natural Resources University, Iran, she has made significant contributions to cancer research, bacterial and viral infections, and peptide-based therapeutic designs. With a strong academic foundation, Dr. Mehralitabar’s Ph.D. in Biophysics from Tarbiat Modares University centered on self-assembling peptide nanofibers, laying the groundwork for her innovative approaches in neural stem cell differentiation. Her work is marked by numerous high-impact publications and collaborations in computational biology and molecular simulations. As a researcher and educator, she has excelled in both wet lab and computational biology skills, mentoring students and contributing to interdisciplinary scientific advancements.

Professional Profile

Google scholar

Orcid

Summary of Suitability for the Research for Women Researcher Award

Havva Mehralitabar Firozjah is an outstanding candidate for the Research for Women Researcher Award based on her impressive academic background, diverse research experience, and contributions to science. With a Ph.D. in Biophysics from Tarbiat Modares University and a focus on molecular dynamics, she has worked on pioneering projects in cancer, bacterial and viral infections, and nanotechnology. Her research skills, particularly in computational biology and molecular dynamics simulations, are extensive, covering critical areas like protein modeling, molecular docking, and bioactive peptide design.

🎓  Education 

Dr. Havva Mehralitabar Firozjah’s academic journey is marked by excellence and dedication to biophysics and molecular biology. She earned her Ph.D. in Biophysics (2013-2018) from Tarbiat Modares University, Tehran, where her thesis on self-assembling alkylated peptide nanofibers provided a unique perspective on neural differentiation. Before this, she completed her M.Sc. in Biophysics (2009-2012) at the Institute for Advanced Studies of Basic Sciences (IASBS), Zanjan, where she investigated the thermodynamic interactions between Doxorubicin and DNA. Dr. Mehralitabar also holds a B.Sc. in Plant Biology (2004-2008) from Alzahra University, Tehran. Her research focus spans molecular dynamics simulations and computational biology, and she has developed deep expertise in both theoretical and practical applications of biophysics, laying a strong foundation for her groundbreaking research in peptide-based therapeutic designs and biomolecular structures.

 💼    Experience

Dr. Havva Mehralitabar Firozjah has accumulated extensive research experience across various scientific domains. She is currently a researcher (2020-2023) at Sari Agricultural Sciences and Natural Resources University, focusing on in silico studies of lactoferrin mechanisms in cancer and bacterial infections. Prior to this, she served as a consultant (2018-2020) at Hakim Sabzevari University, guiding M.Sc. students in molecular dynamics simulations. As an adjunct professor (2019-2022), she taught advanced courses in system biology and molecular docking methods, further shaping young scientists. Her experience in both wet labs and computational biology makes her a versatile scientist, skilled in molecular simulations, peptide design, and biophysics research. Through multiple collaborations and supervisory roles, Dr. Mehralitabar has played a key role in advancing research in the field of molecular biology and nanotechnology.

🏅 Awards and Honors 

Dr. Havva Mehralitabar Firozjah’s contributions to biophysics have earned her numerous awards and recognitions. Notably, she secured 6th place in the National Ph.D. Entrance Exam (2013) out of 120 participants, showcasing her academic prowess. She has also served as a reviewer for the esteemed Journal of Computer in Biology and Medicine (2020-2022), underlining her expertise in computational biology. During her academic tenure, Dr. Mehralitabar received several honors for her innovative research in molecular dynamics simulations and peptide nanotechnology, including recognition from Tarbiat Modares University for her exceptional Ph.D. thesis on alkylated-peptide nanofibers. Additionally, her active participation in conferences and workshops has led to several poster presentations, contributing to her standing as a thought leader in her field. Her relentless pursuit of scientific excellence continues to make a significant impact on the biophysics research community.

🌍 Research Focus 

Dr. Havva Mehralitabar Firozjah’s research primarily revolves around molecular dynamics simulations, peptide design, and nanotechnology. Her work focuses on exploring the interactions between peptides and biological molecules to develop innovative therapeutic strategies. One of her most notable projects includes in silico studies of lactoferrin mechanisms, aiming to address cancer, bacterial, and viral infections. She also specializes in self-assembling peptides for neural stem cell differentiation, demonstrating the potential of biomaterials in regenerative medicine. Dr. Mehralitabar’s research extends into the structural dynamics of proteins, molecular docking, and simulations to understand how molecular structures influence biological functions. With extensive expertise in computational biology and hands-on molecular biology techniques, her work integrates theoretical approaches with practical lab results, making strides in drug design and biomolecular engineering.

📖 Publication Top Notes

  • A combination of bioactive and nonbioactive alkyl-peptides form a more stable nanofiber structure for differentiating neural stem cells: a molecular dynamics simulation survey
    Citations: 9
  • Abiraterone and D4, 3-keto Abiraterone binding to CYP17A1, a structural comparison study by molecular dynamic simulation
    Citations: 3
  •  The role of Wnt palmitoleylated loop conserved disulfide bonds in Wnt-frizzled complex structural dynamics: Insights from molecular dynamics simulations
    Citations: 1
  • The physicochemical properties role of a functionalized alkyl-peptide in nanofibre formation and neural progenitor cells viability and survival
    Citations: 1
  •  In vitro study of the expression of autophagy genes ATG101, mTOR and AMPK in breast cancer with treatment of lactoferrin and in silico study of their communication networks and …

Mr. Malu Daniel | Biotechnology | Research Excellence Award

Posted on by sciencefather

Mr. Malu Daniel | Biotechnology | Research Excellence Award

Mr. Malu Daniel, University of Calabar, Calabar, Nigeria, Nigeria

MR. DANIEL GATIE MALU is a dynamic researcher with a B.Sc. in Genetics and Biotechnology from the University of Calabar, Nigeria. His expertise lies in drug design, discovery, and molecular docking, where he utilizes computational techniques such as density functional theory (DFT) to address complex scientific challenges. His passion for drug delivery systems, particularly for genetic disorders like Cystic Fibrosis and cancers, fuels his ongoing research. Throughout his academic journey, Daniel has developed strong problem-solving skills, a collaborative mindset, and a commitment to scientific integrity. He is currently involved in a research program at the University of Calabar, where he is utilizing advanced computational tools to contribute to biosensor development, biomarkers, and drug modeling. He aims to further his knowledge through a Master’s degree, focusing on theoretical and computational modeling, with a drive to innovate in pharmaceutical and chemical research.

Professional Profile

Orcid

Summary of Suitability for the Award

MR. DANIEL GATIE MALU’s academic achievements, research experience, and dedication to utilizing advanced computational methods for drug design and bio-simulation, he is a strong candidate for the ‘Research for Excellence Award.’ His contributions to multidisciplinary research and his commitment to addressing critical global health issues through innovative scientific solutions make him well-suited for this recognition. His work has the potential for significant scientific impact, aligning well with the award’s criteria for research excellence.

🎓Education 

Daniel Gatie Malu holds a B.Sc. in Genetics and Biotechnology from the University of Calabar, Nigeria, graduating in 2024. His undergraduate thesis, titled “Molecular Modeling of the Spectroscopic Structural and Bioactive Potential of Azadirachta indica against Plasmodium falciparum”, highlights his deep interest in molecular modeling and drug discovery. Daniel explored phytochemical analysis, including GCMS, HPLC, FT-IR, and UV-Vis analysis, to investigate the bioactive potential of plant compounds. His academic focus was on theoretical and experimental approaches to understanding drug interactions with biological systems, utilizing modern computational techniques. The thesis also involved evaluating stability, reactivity, and binding potential of compounds, laying a strong foundation for his future research endeavors. This academic background equipped him with a solid understanding of computational biology, molecular chemistry, and bioinformatics, and he seeks to apply this knowledge to cutting-edge research in drug design and theoretical modeling.

 💼 Experience 

MR. DANIEL GATIE MALU has a diverse research background, starting with his industrial training at Biggmade Scientific Research Academy in 2023. There, he conducted serological tests and explored bioinformatics, focusing on drug-protein interactions. He also performed DNA extraction and plant tissue culture. Since November 2023, he has been part of the Computational and Bio-Simulation Research Group at the University of Calabar, where he is immersed in full-time research. Daniel leverages advanced computational tools such as Gaussian 16, AutoDock Vina, and PyMOL to conduct molecular docking and density functional theory (DFT) studies. His interdisciplinary research spans biosensors, biomarkers, and drug delivery systems. He has also contributed to academic publications and collaborated with peers across various scientific disciplines. Daniel’s mentorship of students and his role in academic projects demonstrate his commitment to fostering intellectual growth within his community.

🏅Awards and Honors 

Daniel Gatie Malu has earned recognition for his academic excellence and contributions to scientific research. In 2024, he became a student member of the Royal Society of Chemistry, which highlights his growing prominence in the field. His work has been instrumental in several key publications and research projects, earning him respect among his peers and mentors. His interdisciplinary research, particularly in molecular docking, density functional theory (DFT), and computational modeling, has been acknowledged within the scientific community. Throughout his academic career, Daniel has demonstrated a strong commitment to advancing knowledge in the fields of biotechnology and drug design, earning him multiple awards for his research contributions at the university level. His passion for innovative solutions in drug delivery and biosensor development has also positioned him as an emerging leader in computational biology and pharmaceutical research.

🌍 Research Focus 

Daniel Gatie Malu’s research focus lies at the intersection of computational chemistry, molecular biology, and drug discovery. He employs density functional theory (DFT) and molecular docking techniques to investigate drug-target interactions, specifically for diseases like Cystic Fibrosis, Huntington’s Disease, and various cancers (BRCA1/BRCA2). Daniel is particularly interested in the design of advanced drug delivery systems such as nanoparticles and liposomes for controlled release and targeted therapies. He also explores high-throughput screening (HTS) to identify active compounds from chemical libraries, focusing on improving the pharmacokinetic and safety profiles of potential drug candidates. Additionally, Daniel investigates the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of these compounds. His interdisciplinary research extends to biosensors and biomarkers, leveraging computational methods for innovative applications in both pharmaceuticals and environmental sciences.

📖 Publications Top Notes

How does the long G·G* Watson-Crick DNA base mispair comprising keto and enol tautomers of the guanine tautomerise? The results of a QM/QTAIM investigation.